Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management

E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment

JL Bennett, F Costello, JJ Chen, A Petzold… - The Lancet …, 2023 - thelancet.com
Optic neuritis is an inflammatory optic neuropathy that is commonly indicative of autoimmune
neurological disorders including multiple sclerosis, myelin-oligodendrocyte glycoprotein …

Long-term effectiveness and safety of rituximab in neuromyelitis optica spectrum disorder and MOG antibody disease

P Barreras, ES Vasileiou, AG Filippatou, KC Fitzgerald… - Neurology, 2022 - AAN Enterprises
Background and Objectives Rituximab is used widely for relapse prevention in neuromyelitis
optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein (MOG)-IgG …

[HTML][HTML] EU paediatric MOG consortium consensus: Part 5–Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

AL Bruijstens, EM Wendel, C Lechner, F Bartels… - European Journal of …, 2020 - Elsevier
In recent years, the understanding about the different clinical phenotypes, diagnostic and
prognostic factors of myelin oligodendrocyte glycoprotein-antibody-associated disorders …

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges

A Al-Ani, JJ Chen, F Costello - Journal of Neurology, 2023 - Springer
New diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease
(MOGAD) have recently been proposed, distinguishing this syndrome from other …

Predictors of relapse in MOG antibody associated disease: a cohort study

S Huda, D Whittam, R Jackson, V Karthikeayan… - BMJ open, 2021 - bmjopen.bmj.com
Objective To identify factors predictive of relapse risk and disability in myelin
oligodendrocyte glycoprotein associated disease (MOGAD). Setting Patients were seen by …

An update on optic neuritis

JA Kraker, JJ Chen - Journal of Neurology, 2023 - Springer
Optic neuritis (ON) is the most common cause of subacute optic neuropathy in young adults.
Although most cases of optic neuritis (ON) are classified as typical, meaning idiopathic or …

Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care

G Fadda, T Armangue, Y Hacohen, T Chitnis… - The Lancet …, 2021 - thelancet.com
The field of acquired CNS neuroimmune demyelination in children is transforming. Progress
in assay development, refinement of diagnostic criteria, increased biological insights …

Neuromyelitis optica spectrum disorders

S Paul, GP Mondal, R Bhattacharyya, KC Ghosh… - Journal of the …, 2021 - Elsevier
The disease concept of Neuromyelitis Optica Spectrum Disorders (NMOSD) has undergone
a significant change over the last two decades including the detection of Myelin …

Treatment and relapse prevention of typical and atypical optic neuritis

G Saitakis, BK Chwalisz - International Journal of Molecular Sciences, 2022 - mdpi.com
Optic neuritis (ON) is an inflammatory condition involving the optic nerve. Several important
typical and atypical ON variants are now recognized. Typical ON has a more favorable …